When researchers compared brain MRI scans of patients who had previously received gadobutrol, a common gadolinium-based contrast agent (GBCA), with patients not exposed to gadobutrol, they did not observe any visual signal intensity changes. The team noted, however, that patients who received gadobutrol had shorter T1 relaxation times of the globus pallidus.

The higher dose of radiation required to x-ray extremely obese patients increases those patients’ risk of cancer, according to new research published in the Journal of Radiological Protection. The chances of getting cancer due to undergoing an x-ray are still quite low, the authors added.

IRadimed announced Wednesday, Dec. 19, that the company has gained FDA clearance for its 3883 MRI-compatible blood pressure module.

Teenagers hit by thoracic lymphoma can be safely and effectively imaged for primary staging and follow-up care with MRI unenhanced by gadolinium-based contrast agents—or by any contrast at all.

MRI scans can be used to monitor liver fat levels in obese patients who undergo bariatric surgery, according to new findings published in Radiology.

A new draft guidance from the FDA aims to clarify the agency’s policies concerning the production of diagnostic x-ray systems. The guidance, “Clarification of Radiation Control Regulations for Manufacturers of Diagnostic X-Ray Equipment,” once finalized, would replace the FDA’s previous guidance on this issue from 1989.

An MRI scan using diffusion tensor imaging of a mouse kidney has won publisher BMC’s "Research in progress" photo competition, which included more than 370 entrants.

Kamil Ugurbil, PhD, director of the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota, will receive the 2019 Institute of Electrical and Electronics Engineers (IEEE) Medal for Innovations in Healthcare Technology “for pioneering the development and leading the advancement of ultra-high-field MRI technology for biomedical and brain research.”